Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Interferon Alpha-2a Biosimilar Market Data Survey Report 2025

  • HEY2806704
  • 74 Pages
  • November 2018
  • Medical Devices
Download Sample    Get Discount   
 
Summary

Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. An oral form is being developed by Amarillo Biosciences.

The global Interferon Alpha-2a Biosimilar market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:

Global market size and forecast

Regional market size, production data and export & import

Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)

Major Application

Major Type

Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:

Roche

Biosidus

Zydus Cadila

Nanogen

Amega Biotech

Rhein Minapharm Biogenetics

Rhein Minapharm Biogenetics

3sbio

Major applications as follows:

Hepatitis C

Hepatitis B

Other

Major Type as follows:

Long-lasting Type

Ordinary Type

Regional market size, production data and export & import:

Asia-Pacific

North America

Europe

South America

Middle East & Africa

Table of Contents

1 Global Market Overview

1.1 Scope of Statistics

1.1.1 Scope of Products

1.1.2 Scope of Manufacturers

1.1.3 Scope of Application

1.1.5 Scope of Regions/Countries

1.2 Global Market Size

2 Regional Market

2.1 Regional Production

2.2 Regional Demand

2.3 Regional Trade

3 Key Manufacturers

3.1 Roche

3.1.2 Company Information

3.1.2 Product Specifications

3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.2 Biosidus

3.2.1 Company Information

3.2.2 Product Specifications

3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.3 Zydus Cadila

3.3.1 Company Information

3.3.2 Product Specifications

3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.4 Nanogen

3.4.1 Company Information

3.4.2 Product Specifications

3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.5 Amega Biotech

3.5.1 Company Information

3.5.2 Product Specifications

3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.6 Rhein Minapharm Biogenetics

3.6.1 Company Information

3.6.2 Product Specifications

3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.7 Rhein Minapharm Biogenetics

3.7.1 Company Information

3.7.2 Product Specifications

3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

3.8 3sbio

3.8.1 Company Information

3.8.2 Product Specifications

3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

4 Major Application

4.1 Hepatitis C

4.1.1 Overview

4.1.2 Hepatitis C Market Size and Forecast

4.2 Hepatitis B

4.2.1 Overview

4.2.2 Hepatitis B Market Size and Forecast

4.3 Other

4.3.1 Overview

4.3.2 Other Market Size and Forecast

5 Market by Type

5.1 Long-lasting Type

5.1.1 Overview

5.1.2 Long-lasting Type Market Size and Forecast

5.2 Ordinary Type

5.2.1 Overview

5.2.2 Ordinary Type Market Size and Forecast

6 Conclusion

Tab Regional Production 2011-2017 (Million USD)

Tab Regional Production 2011-2017 (Volume)

Tab Regional Demand and CAGR 2011-2017 (Million USD)

Tab Regional Demand and CAGR 2011-2017 (Volume)

Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)

Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)

Tab Regional Export 2011-2017 (Million USD)

Tab Regional Export 2011-2017 (Volume)

Tab Regional Import 2011-2017 (Million USD)

Tab Regional Import 2011-2017 (Volume)

Tab Sales Revenue, Volume, Price, Cost and Margin of Roche

Tab Sales Revenue, Volume, Price, Cost and Margin of Biosidus

Tab Sales Revenue, Volume, Price, Cost and Margin of Zydus Cadila

Tab Sales Revenue, Volume, Price, Cost and Margin of Nanogen

Tab Sales Revenue, Volume, Price, Cost and Margin of Amega Biotech

Tab Sales Revenue, Volume, Price, Cost and Margin of Rhein Minapharm Biogenetics

Tab Sales Revenue, Volume, Price, Cost and Margin of Rhein Minapharm Biogenetics

Tab Sales Revenue, Volume, Price, Cost and Margin of 3sbio

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450